I.

Introduction:
Tuberous sclerosis complex(TSC) is an autosomal dominant genetic disease that is characterised by presence of hamartomas in multiple organ systems.
Classically, TSC has been characterized by clinical triad of mental retardation, epilepsy, and skin lesions known as adenoma sebaceum. Though recent studies have shown that half of affected patients have normal intelligence , with 75% having epilepsy, with almost any organ of body being affected.
Neuroimaging plays an important role in making the diagnosis of TSC,as the characteristics abnormalities are present in about 95 % of the cases.
The neuroimaging findings are usually present before the time of the birth, whereas other clinical findings like adenoma sebaceum develop later on in childhood.
The common neuroimaging abnormalities found in TSC are cortical tubers, subependymal nodules, subependymal giant cell astrocytoma, white matter migration lines, and cerebral cortical dysplasias.
Radiological confirmation has been proved to be sufficient for the confirmation of the lesions. Child had an uneventful birth history, now presents with delayed myelination and epilepsy since 6 months of age. Child has poor cry and is drowsy.
II.
Imaging: Multiple T2, FLAIR and Diffusion weighted hypointense and T1 isointense subependymal nodules along the lateral ventricles on both sides which suggest presence of calcified nodules. Multiple cortical tubers with white matter migration lines were seen in bilateral supratentorial white matter. There was moderate thinning of corpus callosum with mild frontal and temporal atrophy Tuberous sclerosis complex is a neurocutaneous syndrome characterized by the formation of non-malignant hamartomas and neoplastic lesions in the brain, heart, skin, kidney, lung, and other organs. It is associated with autism, seizures, and neurocognitive and behavioral disabilities. Because its clinical manifestations vary widely, establishing the diagnosis of tuberous sclerosis complex was particularly challenging prior to the advent of modern neuroimaging and genetic phenotyping. Mutations that lead to increased mTOR activation promote cellular disorganization, overgrowth, and abnormal differentiation that may result in tumorigenesis.
Presentation.TSC patients generally present within the first two decades of life. The most common skin lesions are hypomelanotic macules, which are ovoid depigmented areas with irregular margins that are best visualized by ultraviolet light (Woods lamp). These -ash leaf‖ spots are seen in over 90% of cases and may be the first visible manifestation of TSC. Other common cutaneous findings such as forehead plaques, shagreen patches , facial angiofibromas (-adenoma sebaceum‖), and periungual fibromas usually do not appear until after puberty. 
IntracranialManifestations:
The four major pathologic features of TSC in the brain -cerebral tubers, subependymal nodules, white matter lesions, and subependymal giant cell astrocytoma Three minor features which present with a lesser frequency than the major ones -parenchymal cysts, cerebellar lesions and vascular lesions.
Cerebral Tubers.Cerebral tubers or hamartomas are firm, whitish, pyramid-shaped, elevated areas of smooth gyral thickening, with or without central depressions that grossly resemble potatoes (-tubers‖).
Microscopically, cortical tubers consist of giant cells and dysmorphic neurons with foci of gliosis, disrupted lamination, and disordered myelin. Balloon cells similar to those seen in Taylor-type focal cortical dysplasia (FCD IIb) are also commonly found in tubers. Tubers do not undergo malignant transformation.
They are most common supratentoriarly, though around 15 % may have in the cerebellum The proportion that calcifies is not known but there is seen an increase in calcified tubers with increase in age , presenting around 50 % in patients above 10 years of age Neonatal and infantile cortical tubers are initially seen as hypodense cortical/subcortical masses within broadened and expanded gyri . The lucency decreases with age; tubers in older children and adults are mostly isodense with cortex this maybe attributed to the myelination of white matter. FLAIR images best depict parenchymal lesions in a myelinated brain.
Tubers are almost always located in the subcortical regions , separate from the overlying cortex. Cysts also are seen within the tubers in myelinated mature brains and represent a more aggressive phenotype. On MR perfusion most of the tubers appear hypoperfused.On MR spectroscopy the tubers showed mildly elevated choline and decreased NAA peaks with increased myo-inositol peaks on short TE (20-30 msec).
SubependymalNodules: Subependymal nodules (SENs) are located immediately beneath the ependymal lining of the lateral ventricles, along the course of the caudate nucleus. They are the most common intracranial manifestation.
SENs appear as elevated, rounded, hamartomatous lesions that grossly resemble candle guttering or drippings. They often calcify with increasing age. SENs along the caudothalamic groove adjacent to the foramen of Monro may undergo neoplastic transformation into subependymal giant cell astrocytoma.
SENs are rarely calcified in the first year of life. Calcification in SENs increases with age. Eventually, 50% demonstrate some degree of globular calcification. SENs typically do not enhance on CECT scans. An enhancing or enlarging SEN-especially if located near the foramen of Monro-is suspicious for SEGA. They usually have increased diffusivity and reduced fractional anisotropy compared to the surrounding white matter.
White Matter Lesions. White matter (WM) lesions are almost universal in patients with TSC. They appear as foci of bizarre dysmorphic neurons and balloon cells in the subcortical WM and/or fine radial lines extending outward from the lateral ventricles.
These white matter foci contain areas of hypomyelination similar to those seen in cerebral tubers. These lesions are usually missed on CT scans, on MR imaging they are usually seen to to course through the entire cerebral mantle.
Subependymal Giant Cell Astrocytoma (SEGA)-also known as subependymal giant cell tumor-is seen almost exclusively in the setting of TSC. Grossly, SEGAs appear as well-circumscribed solid intraventricular masses located near the foramen of Monro. SEGAs are WHO grade I tumors that often cause obstructive hydrocephalus but do not invade adjacent brain. While most SEGAs are unilateral, bilateral tumors occur in 10-15% of cases. Typical microscopic features are large (not truly giant), plump cells that resemble astrocytes and/or ganglion cells in a fibrillar background. Tumor cell GFAP positivity varies, but most SEGAs are positive for neurofilament protein, neuron-specific enolase, and synaptophysin on immunohistochemistry. Intratumoral calcifications are relatively common, but necrosis is rare. Mitoses are few, and the MIB-1 index is generally low.
Subependymal giant cell astrocytoma.While SEGAs can occur anywhere along the ventricular ependyma, the vast majority are found near the foramen of Monro. SEGAs are mixed signal intensity on both T1and T2WI. Virtually all enhance moderately strongly on T1 C+ scans. SEGAs become symptomatic when they obstruct the foramen of Monro and cause hydrocephalus. Even large SEGAs rarely invade brain.
Parenchymal Cysts: An unknown number of patients with TSC show parenchymal cystic benign lesions, usually in the periventricular regions. There clinical significance is not yet certain.
CerebellarLesions: They are less common presenting around 15%, when present they show similar features like in the cerebral hemispheres.
VascularLesions: These are very rare, and may present as aneurysms in the internal carotid and anterior cerebral artery territory, better appreciated on angiography.
IV. Conclusion
Neuroimaging in a small series of patients with tuberous sclerosis and mental retardation and epilepsy revealed severely afflicted brains with more white matter anomalies, subependymal nodules, SGCA, transmantle dysplasias and cerebral tubers.
Neuroimaging plays a vital role in the diagnosis of the TSC,and is often a conclusive and characteristic , on most occasions not requiring further follow ups.
